Our primary results indicate that t(8,21) AML patients with KIT mutations should be evaluated according to ethnicity, which is consistent with other studies [3, 6, 9, 11, 39] and partially explained the uncertain role of KIT mutations in OS of t(8,21) AML as an entity in the present analysis. This evidence concerns the gene KIT and acute myeloid leukemia.